Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000993713 | SCV002246439 | pathogenic | Sandhoff disease | 2021-11-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HEXB protein function. ClinVar contains an entry for this variant (Variation ID: 800653). This missense change has been observed in individual(s) with Sandhoff disease (PMID: 33407268). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 254 of the HEXB protein (p.Leu254Ser). |
Department of Pediatrics, |
RCV000993713 | SCV000999190 | likely pathogenic | Sandhoff disease | 2019-11-26 | no assertion criteria provided | research | The patient showed classical presentation of with infantile onset Sandhoff disease plus deficient enzyme activity in leukocytes. |